Tivic Health Systems Inc - רווח נקי למניה אחת בשנים עשר החודשים האחרונים TIVC
Current sales of ClearUP physiotherapy provide Tivic Health Systems with real market revenue. A year-over-year EPS (TTM) comparison on GURU.Markets shows that the metric stands at 81.70. The company implements bioelectronic pulses as a drug-free alternative for sinus pain, applying physics to medicine. A unique patent portfolio and FDA approval protect this microcurrent therapy pioneer from competition.
פילוחי מדדים פיננסיים ומדדי שוק עבור Tivic Health Systems (TIVC)
Earnings per share dynamics over the last twelve months reflect the rate of change in the business's net yield compared to the previous year. This indicator measures capitalization efficiency and the real liquidity of the company. For Tivic Health Systems (TIVC), this serves as a metric for the commercialization of ClearUP devices within the bioelectronic therapy segment. By analyzing the comparable year-over-year growth of EPS TTM, an investor assesses the scalability of non-invasive treatment. Sharp spikes in the trend line warrant caution due to the risk of a subsequent decline in margins.
